Date published: 2026-6-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

Sur-8 Activators

SHOC2 Leucine Rich Repeat Scaffold Protein (SHOC2), encoded by the SHOC2 gene in humans, is a critical component of the RAS-MAPK signaling pathway. This signaling pathway is important in cell proliferation, differentiation, and survival.SHOC2 functions as a scaffold protein, a type of protein that does not directly catalyze reactions but instead facilitates signal transduction by bringing together other proteins into complexes. Specifically, SHOC2 promotes the dephosphorylation and activation of RAF proteins, which are key players in the RAS-MAPK pathway.

The protein contains several leucine-rich repeats (LRRs), structural motifs often involved in protein-protein interactions. These repeats enable SHOC2 to interact with various proteins within the RAS-MAPK pathway, facilitating signal transduction.Mutations in the SHOC2 gene can lead to an increased activity of the RAS-MAPK pathway. A specific mutation, leading to a S2G change in SHOC2, has been associated with a condition called Noonan-like syndrome with loose anagen hair, characterized by features such as distinctive facial features, short stature, heart defects, and developmental delay. This mutation disrupts the normal localization of SHOC2 within the cell, enhancing RAS-MAPK signaling.In summary, SHOC2 is a scaffold protein involved in the RAS-MAPK signaling pathway. It facilitates signal transduction by bringing together various proteins into functional complexes. Mutations in SHOC2 can lead to hyperactivation of the RAS-MAPK pathway, contributing to conditions such as Noonan-like syndrome with loose anagen hair.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

MEK inhibitors can indirectly influence SHOC2 function by modulating the ERK/MAPK pathway, which SHOC2 helps regulate.

SCH772984

942183-80-4sc-473205
5 mg
$370.00
5
(0)

By inhibiting ERK, these compounds can affect downstream signaling of the RAS-MAPK pathway, potentially impacting SHOC2 function.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

RAF inhibitors can affect the upstream signaling of the RAS-MAPK pathway, potentially altering SHOC2-mediated processes.

Tipifarnib

192185-72-1sc-364637
10 mg
$720.00
(0)

These inhibitors affect the post-translational modification of RAS, potentially influencing SHOC2's role in RAS-MAPK signaling.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitors may indirectly affect SHOC2 function by altering protein degradation pathways.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Tyrosine kinase inhibitors can affect various signaling pathways, potentially influencing SHOC2's role in cell signaling.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

These inhibitors can change gene expression patterns, possibly affecting SHOC2 expression.

L-Tryptophan

73-22-3sc-280888
sc-280888A
sc-280888B
100 g
1 kg
5 kg
$129.00
$364.00
$1795.00
(0)

Wnt pathway activators may indirectly modulate SHOC2 function by influencing its expression during cellular signaling.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

HSP90 inhibitors can disrupt protein folding and function, potentially affecting proteins involved in signaling pathways like SHOC2.